Advances in cancer treatment and supportive care have improved the results and tolerability of blood and marrow transplants (BMT). However, BMT remains a major procedure.

In an allogeneic transplant, the patient receives bone marrow or stem cells from a tissue-matched (HLA-matched) donor who may or may not be a relative.

An allogeneic BMT offers the chance of a cure to patients with a variety of cancers, including: